674. Long Term Safety of Clinical Grade LentiGlobin Vectors in a Γ-Thalassemic and Normal Mice

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)35009-2
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Therapeutic Benefits in Thalassemic Mice Transplanted With Long-Term−cultured Bone Marrow Cells

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2011English

Efficacy and Safety of Long-Term Prophylaxis in Severe Hemophilia a Dogs Following Liver Gene Therapy Using AAV Vectors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Long-Term Treatment With High-Dose of Sildenafil in a Thalassemic Patient With Pulmonary Hypertension

Monaldi Archives for Chest Disease
Cardiovascular MedicinePulmonaryRespiratory MedicineCardiology
2015English

Long-Term Gene Therapy With Del1 Fragment Using Nonviral Vectors in Mice With Explanted Tumors

OncoTargets and Therapy
OncologyPharmacology
2016English

Long-Term Clinical Course of Normal-Tension Glaucoma: 20 Years of Experience

Journal of Ophthalmology
Ophthalmology
2017English

OP0105 Long-Term Safety of Tocilizumab From Large Clinical Trial and Postmarketing Populations

2017English

Tofacitinib: Efficiency and Safety in Long-Term Use

Medical Council
2019English

Long-Term Clinical Efficacy and Safety of Secukinumab for Japanese Patients With Psoriasis: A Single-Center Experience

Journal of Dermatology
DermatologyMedicine
2017English

Grade v Renal Injury – Short and Long Term Outcome

Open Journal of Trauma
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy